title: The cardiovascular safety of azithromycin.
authors.affiliation: Sunnybrook Research Institute and the Departments of Medicine and Paediatrics, University of Toronto, Toronto, Ont. dnj@ices.on.ca.
authors.forename: David N
authors.initials: DN
authors.lastname: Juurlink
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000382:microbiology*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides
references.citation: Antimicrob Agents Chemother. 2000 Oct;44(10):2630-7
references.pmid: 10991836
references.citation: N Engl J Med. 2013 May 2;368(18):1704-12
references.pmid: 23635050
references.citation: JAMA. 2014 Jun 4;311(21):2199-208
references.pmid: 24893087
references.citation: Am J Health Syst Pharm. 2007 Apr 15;64(8):830-6
references.pmid: 17420199
references.citation: Am J Respir Crit Care Med. 2014 May 15;189(10):1173-80
references.pmid: 24707986
references.citation: CMAJ. 2011 Feb 22;183(3):303-7
references.pmid: 21242274
references.citation: N Engl J Med. 2012 May 17;366(20):1881-90
references.pmid: 22591294
references.citation: N Engl J Med. 2004 Sep 9;351(11):1053-6
references.pmid: 15356302
references.citation: J Pharmacol Exp Ther. 2002 Oct;303(1):218-25
references.pmid: 12235254
references.citation: N Engl J Med. 2013 May 2;368(18):1665-8
references.pmid: 23635046